About Oncodesign Services
Oncodesign Services is a company based in Dijon (France) founded in 1995.. Oncodesign Services has raised $23.96 million across 1 funding round from investors including Eurazeo. Oncodesign Services has completed 1 acquisition, including ZoBio. Oncodesign Services offers products and services including Medicinal Chemistry Services, In Vivo Pharmacology, and DMPK Services. Oncodesign Services operates in a competitive market with competitors including BioTelemetry, Calyx, Molecular NeuroImaging, Imaging Endpoints and CROmed, among others.
- Headquarter Dijon, France
-
Sectors
Healthcare
-
Phone
*********
-
Website
*********
-
Social
*********
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Products & Services of Oncodesign Services
Oncodesign Services offers a comprehensive portfolio of products and services, including Medicinal Chemistry Services, In Vivo Pharmacology, and DMPK Services. The company's diverse product and service offerings are designed to meet the evolving needs of its customers, address market demands, and provide comprehensive solutions that drive value creation and customer satisfaction across various segments and use cases.
Designs and synthesizes compounds for therapeutic development
Conducts studies on drug efficacy in animal models
Evaluates drug metabolism and pharmacokinetics
Unlock access to complete
Funding Insights of Oncodesign Services
Oncodesign Services has successfully raised a total of $23.96M through 1 strategic funding round. The most recent funding activity was a Private Equity Round round of $23.96 million completed in January 2024. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
- Total Funding Total Funding
- Total Rounds 1
- Last Round Private Equity Round — $24.0M
-
First Round
First Round
(23 Jan 2024)
- Investors Count 1
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jan, 2024 | Amount | Private Equity Round - Oncodesign Services | Valuation | Eurazeo |
|
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
Investors in Oncodesign Services
Oncodesign Services has secured backing from 1 investor, including venture fund investors. Prominent investors backing the company include Eurazeo. This diverse investor base provides strategic capital, industry expertise, and valuable network connections that support the company's growth initiatives, market expansion, and long-term value creation.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Private equity and debt investments are managed across multiple sectors.
|
Founded Year | Domain | Location |
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Single family office of Amitabh Bachchan, founder of Amitabh Bachchan Corporation or AB CORP
|
Founded Year | Domain | Location | |
|
Startup ecosystems are ignited through strategic investments by Signite Partners.
|
Founded Year | Domain | Location | |
|
Venture capital is directed toward companies in multiple sectors.
|
Founded Year | Domain | Location | |
|
Venture capital is invested in cybersecurity, fintech, and AI startups.
|
Founded Year | Domain | Location |
Investments & Acquisitions by Oncodesign Services
Oncodesign Services has strategically engaged in corporate development activities, having acquired 1 company. Notable acquisitions include ZoBio. These strategic investments and acquisitions demonstrate the company's commitment to growth through portfolio expansion, market consolidation, technology integration, and strategic partnerships that enhance competitive positioning and drive long-term value creation.
| Company Name | Description | Domain | Location | Founded Year | Amount |
|---|---|---|---|---|---|
|
Bionic investment advisor platform
|
2016 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 | ||||
|
Physical e-commerce kiosks are deployed for rural purchases in Indonesia.
|
2014 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 |
| Company Name | Description | Domain | Location | Founded Year | Amount |
|---|---|---|---|---|---|
|
Provider of fragment-based drug discovery services
|
2004 |
| Company Name | Description | Domain | Location | Founded Year | Amount |
|---|---|---|---|---|---|
|
OVO is recognized as a smart digital payment application.
|
2017 | ||||
|
Bionic investment advisor platform
|
2016 | ||||
|
Physical e-commerce kiosks are deployed for rural purchases in Indonesia.
|
2014 | ||||
|
Physical e-commerce kiosks are deployed for rural purchases in Indonesia.
|
2014 |
Financial Statements - Oncodesign Services
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
Oncodesign Services Comparisons
Competitors of Oncodesign Services
Oncodesign Services operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as BioTelemetry, Calyx, Molecular NeuroImaging, Imaging Endpoints and CROmed, among others. This competitive environment drives innovation, market differentiation, and strategic positioning as companies strive to capture market share and deliver value to their customers. Understanding the competitive dynamics is crucial for assessing market positioning, identifying growth opportunities, and navigating the challenges inherent in a competitive marketplace.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
Wireless products for monitoring health parameters are offered.
|
|
| domain | founded_year | HQ Location |
CRO providing imaging services for clinical development
|
|
| domain | founded_year | HQ Location |
Company offering specialized imaging services for neurodegenerative and neuropsychiatric disorders
|
|
| domain | founded_year | HQ Location |
Offers medical imaging expertise for oncology research and clinical trials globally.
|
|
| domain | founded_year | HQ Location |
Specialized imaging services for preclinical and clinical research are provided.
|
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
Multiple services are booked via an app-based platform.
|
|
| domain | founded_year | HQ Location |
On-demand services are booked through an app-based platform.
|
|
| domain | founded_year | HQ Location |
App based platform offering on demand delivery and ride-hailing services
|
|
| domain | founded_year | HQ Location |
Operates an on-demand hyperlocal delivery app for food and groceries.
|
Latest news on Oncodesign Services
Frequently Asked Questions about Oncodesign Services
When was Oncodesign Services founded?
Oncodesign Services was founded in 1995 and raised its 1st funding round 29 years after it was founded.
Where is Oncodesign Services located?
Oncodesign Services is headquartered in Dijon, France. It is registered at Dijon, Bourgogne-franche-comte, France.
Is Oncodesign Services a funded company?
Oncodesign Services is a funded company, having raised a total of $23.96M across 1 funding round to date. The company's 1st funding round was a Private Equity Round of $23.96M, raised on Jan 23, 2024.
What does Oncodesign Services do?
Oncodesign Services was founded in 1995 in Dijon, France, as a contract research organization specializing in oncology. Drug discovery processes, bioanalysis techniques, and preclinical studies are conducted to support pharmaceutical development. Operations are centered on therapeutic innovation in cancer treatments, with services extending to global clients in the biopharmaceutical sector. Expertise is applied across early-stage research phases to ensure regulatory compliance and scientific accuracy.
Who are the top competitors of Oncodesign Services?
Oncodesign Services's top competitors include BioTelemetry, Calyx and Molecular NeuroImaging.
What products or services does Oncodesign Services offer?
Oncodesign Services offers Medicinal Chemistry Services, In Vivo Pharmacology, and DMPK Services.
How many acquisitions has Oncodesign Services made?
Oncodesign Services has made 1 acquisition, including ZoBio.
Who are Oncodesign Services's investors?
Oncodesign Services has 1 investor. Key investors include Eurazeo.
Book a demo & talk to our team
Share a few details and we’ll reach out to schedule a session.